Antonio Valero Selected Research

rupatadine

1/2020	Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis.
1/2019	Clinically relevant effect of rupatadine 20 mg and 10 mg in seasonal allergic rhinitis: a pooled responder analysis.
11/2013	Evaluation of nasal symptoms induced by platelet activating factor, after nasal challenge in both healthy and allergic rhinitis subjects pretreated with rupatadine, levocetirizine or placebo in a cross-over study design.
1/2009	Safety of rupatadine administered over a period of 1 year in the treatment of persistent allergic rhinitis: a multicentre, open-label study in Spain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Valero Research Topics

Disease

16	Asthma (Bronchial Asthma) 06/2022 - 01/2010
15	Allergic Rhinitis 01/2022 - 01/2009
11	Hypersensitivity (Allergy) 01/2022 - 03/2002
4	Rhinitis 01/2019 - 01/2009
4	Chronic Urticaria 01/2017 - 01/2009
4	Inflammation (Inflammations) 01/2014 - 02/2009
3	Seasonal Allergic Rhinitis (Hay Fever) 01/2019 - 01/2012
3	Urticaria (Hives) 08/2013 - 11/2003
2	Perennial Allergic Rhinitis 01/2020 - 01/2012
2	Anosmia 12/2016 - 01/2012
2	Anaphylaxis (Anaphylactic Shock) 01/2016 - 01/2010
2	Nasal Polyps (Nasal Polyp) 05/2015 - 05/2013
2	Rhinosinusitis 05/2015 - 05/2013
2	Food Hypersensitivity (Food Allergy) 04/2014 - 01/2010
1	Obesity 06/2022
1	Weight Loss (Weight Reduction) 06/2022
1	COVID-19 01/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2020
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 01/2019
1	Hyperplasia 05/2015
1	Eosinophilia 05/2015
1	Rhinorrhea 01/2012
1	Sneezing 01/2012
1	Pruritus (Itching) 01/2012
1	Polyps 02/2011
1	Lung Diseases (Lung Disease) 05/2010
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 05/2010
1	Neural Tube Defects (Exencephaly) 05/2004

Drug/Important Bio-Agent (IBA)

5	AllergensIBA 01/2017 - 01/2010
5	Histamine Antagonists (Antihistamines)IBA 08/2013 - 01/2009
4	rupatadineIBA 01/2020 - 01/2009
4	Omalizumab (Xolair)FDA Link 09/2019 - 09/2013
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 02/2011
4	Immunoglobulin E (IgE)IBA 01/2017 - 01/2012
3	CytokinesIBA 06/2022 - 02/2011
3	Biomarkers (Surrogate Marker)IBA 06/2021 - 12/2016
3	lipid transfer protein (glycolipid transfer protein)IBA 01/2016 - 01/2010
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2016 - 01/2011
3	levocetirizine FDA LinkGeneric 11/2013 - 01/2012
2	Tyrosine (L-Tyrosine)FDA Link 06/2021 - 01/2020
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2021 - 02/2009
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 04/2010
2	Pharmaceutical PreparationsIBA 01/2016 - 09/2012
2	Matrix Metalloproteinases (MMPs)IBA 05/2015 - 05/2013
2	Platelet Activating FactorIBA 11/2013 - 03/2013
2	bilastineIBA 08/2013 - 01/2012
2	desloratadine (Aerius)FDA LinkGeneric 05/2013 - 02/2011
1	AdiponectinIBA 06/2022
1	LeptinIBA 06/2022
1	Biological ProductsIBA 01/2021
1	mepolizumabIBA 10/2020
1	reslizumabIBA 09/2019
1	SolutionsIBA 01/2019
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 03/2018
1	azelastine (Optivar)FDA LinkGeneric 01/2018
1	Fluticasone (Cutivate)FDA LinkGeneric 01/2018
1	anti-IgE antibodiesIBA 01/2017
1	Monoclonal AntibodiesIBA 07/2016
1	Rituximab (Mabthera)FDA Link 10/2015
1	W 12IBA 05/2015
1	CollagenIBA 05/2015
1	fluticasone furoate FDA Link 01/2014
1	Anti-Allergic Agents (Antiallergic Agents)IBA 08/2013
1	Tissue Inhibitor of MetalloproteinasesIBA 05/2013
1	Therapeutic UsesIBA 01/2012
1	Cetirizine (Zyrtec)FDA LinkGeneric 01/2012
1	Omeprazole (Prilosec)FDA LinkGeneric 08/2011
1	Fluoxetine (Prozac)FDA LinkGeneric 08/2011
1	Interleukin-6 (Interleukin 6)IBA 02/2011
1	Bovine Serum AlbuminIBA 02/2011
1	Interleukin-8 (Interleukin 8)IBA 02/2011
1	Mometasone Furoate (Nasonex)FDA LinkGeneric 02/2011
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2011
1	parecoxibIBA 01/2011
1	AntigensIBA 05/2010
1	LipidsIBA 04/2010
1	Folic Acid (Vitamin M)FDA LinkGeneric 05/2004
1	Celecoxib (Celebrex)FDA Link 11/2003
1	Insulin (Novolin)FDA Link 03/2002

Therapy/Procedure

4	Immunotherapy 01/2022 - 07/2011
4	Therapeutics 11/2018 - 09/2013
3	Nebulizers and Vaporizers (Inhaler) 01/2020 - 11/2018
3	Self Medication 04/2019 - 01/2019
1	Bariatric Surgery 06/2022
1	Contraindications 01/2020
1	Biological Therapy 09/2019
1	Dry Powder Inhalers 01/2019
1	Analgesia 01/2011